Krista Isaac DO MS

Robert Reilly, DO, is a board-certified oncologist and hematologist based in Feasterville Trevose, PA, specializing in the diagnosis and treatment of various cancers. He is dedicated to providing individualized treatment plans that prioritize patient needs and quality of life, supported by a compassionate and experienced staff. As the Medical Director of Research at St. Mary Medical Center and chairman of its Cancer Center, Dr. Reilly is committed to advancing cancer care through clinical trials and innovative treatments. His collaborative approach and emphasis on patient support have earned him a reputation for excellence in the oncology field. Generated from the website

Dr. Alexander Ostrovsky is a board-certified oncologist and hematologist based in Feasterville Trevose, PA, specializing in the diagnosis and treatment of various cancers. With a personalized approach to patient care, he collaborates with a dedicated team to explore innovative treatment options, including clinical trials, ensuring patients receive the most promising therapies available. Recognized as one of Philadelphia's top physicians, Dr. Ostrovsky is committed to providing compassionate support throughout the cancer journey. His practice emphasizes clear communication and collaboration, fostering a trusting environment where patients feel heard and cared for during their treatment process. Generated from the website

Daniel J. Lebovic, MD, is a board-certified oncologist and hematologist based in Feasterville Trevose, PA, specializing in the diagnosis and treatment of various cancers. With extensive experience and a commitment to compassionate care, Dr. Lebovic employs advanced therapies to provide his patients with the best possible outcomes. Affiliated with Holy Redeemer and St. Mary Medical Center, Dr. Lebovic has been recognized by his peers in Philadelphia Magazine's Top Doc List for his dedication to patient care. His practice emphasizes collaboration and support, ensuring that patients receive personalized treatment plans and access to clinical trials when appropriate. Generated from the website